OMEROS CORP — Investor Relations & Filings
Filings indexed
763
across all filing types
Latest filing
2026-04-30
Annual Report
Country
US
United States of America
Listing
US
OMER
Omeros Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. The company leverages innovative science to build a diverse pipeline of first-in-class drug candidates designed to address challenging diseases and disorders with significant unmet medical needs. Omeros concentrates on developing therapeutics with novel mechanisms of action that target previously untapped receptors and enzymes, aiming to provide next-generation treatments for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | |
| DEF 14A - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | |
| SCHEDULE 13G/A - OMEROS CORP (0001285819) (Subject) | 2026-03-27 | English | |
| 4 - OMEROS CORP (0001285819) (Issuer) | 2026-02-21 | English | |
| SCHEDULE 13G Filing | 2026-01-30 | English | |
| 4 Filing | 2026-01-14 | English |
Browse filings by year
23 years- 2026 7 filings
- 2025 36 filings
- 2024 29 filings
- 2023 39 filings
- 2022 51 filings
- 2021 37 filings
- 2020 45 filings
- 2019 47 filings
- 2018 36 filings
- 2017 44 filings
- 2016 67 filings
- 2015 45 filings
- 2014 45 filings
- 2013 50 filings
- 2012 42 filings
- 2011 34 filings
- 2010 49 filings
- 2009 39 filings
- 2008 12 filings
- 2007 2 filings
- 2006 2 filings
- 2005 1 filing
- 2004 4 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 39078996 | ARS - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | ||
| 39079103 | DEF 14A - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | ||
| 33062212 | SCHEDULE 13G/A - OMEROS CORP (0001285819) (Subject) | 2026-03-27 | English | ||
| 32700252 | 4 - OMEROS CORP (0001285819) (Issuer) | 2026-02-21 | English | ||
| 28665560 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 28665570 | 4 Filing | 2026-01-14 | English | ||
| 28665565 | 8-K Filing | 2026-01-07 | English | ||
|
2025
8 filings
| |||||
| 11674670 | FORM 8-K | 2025-12-29 | English | ||
| 11674671 | FORM 8-K | 2025-12-01 | English | ||
| 11674672 | Regulatory Filings 2025 | 2025-11-14 | English | ||
| 11674673 | Regulatory Filings 2025 | 2025-11-14 | English | ||
| 11674674 | FORM 10-Q | 2025-11-13 | English | ||
| 11674675 | FORM 8-K | 2025-11-13 | English | ||
| 11674676 | Major Shareholding Notification 2025 | 2025-10-31 | English | ||
| 11674677 | FORM 4 | 2025-10-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CYBIN INC.
A late-stage neuropsychiatry company developing psychedelic…
|
CYBN | CA | Manufacturing |
|
Cyclerion Therapeutics, Inc.
Develops personalized biofeedback therapies for treatment-r…
|
CYCN | US | Manufacturing |
|
Cyfuse Biomedical K.K.
Develops scaffold-free bio 3D printing technology for tissu…
|
4892 | JP | Manufacturing |
|
CYTOKINETICS INC
A late-stage biopharma developing drugs for diseases of imp…
|
CYTK | US | Manufacturing |
|
CytomX Therapeutics, Inc.
Clinical-stage oncology company developing conditionally ac…
|
CTMX | US | Manufacturing |
|
Cytori Cell Research Institute,Inc.
Develops cell therapy medical devices using a patient's own…
|
3750 | JP | Manufacturing |
|
Daan Gene Co., Ltd.
Specializes in molecular diagnostic products and PCR-based …
|
002030 | CN | Manufacturing |
|
Daebonglsco.,Ltd
Develops and supplies raw materials for the pharmaceutical,…
|
078140 | KR | Manufacturing |
|
DaehanPharmaceutical
Researches, develops, and manufactures human/animal pharma …
|
023910 | KR | Manufacturing |
|
DAE HWA PHARM CO., LTD
Pharmaceutical firm developing drugs with proprietary drug …
|
067080 | KR | Manufacturing |
OMEROS CORP via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33369/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33369 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33369 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33369 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33369}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OMEROS CORP (id: 33369)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.